Oxford Cardiomox Ltd.
Contact Person, Position
Oxford Cardiomox Ltd was formed in 2014 by Oxford University Innovation Ltd. The technology was identified during a consulting project to support a leading Ukrainian medical research institute. A Chinese sister company was created in 2016 to access government support and ease entry to the Chinese market. The company raised £2m in 2014. These funds are being used to complete the regulatory approval process for the current Cardiomox MCG scanner in China and Europe. We are now seeking £3m to accelerate sales in China and support entry to the US market.
□ Under development, Lab tested
□ Available for demonstration
□ Field tested, ready for commercialization and scale up
□ Already on market
□ Commercial Agreement with technical assistance
□ Technical Cooperation Agreement
□ Financial Investment Agreement
□ Joint Venture
□ Licensing Agreement
□ Manufacturing Agreement
□ Research Collaboration Agreement
□ Services Agreement
Type of Partner sought: